There has been recent discussion regarding possible extended treatment with forteo . I went to the National Institute of Health site and looked at the Clinical Trials section under forteo to see if there were any tests looking at extended treatment. I didn't find anything regarding extended treatment. I also looked under denosumab and found some interesting studies.

There was also a general information section on clinical trials -how they are conducted etc. What was perhaps of great interest to some here, who can't do bisphophonates after forteo or others as well , is a program called Expanded Access Protocol. Apparently if you do not qualify for a trial because of age, or other conditions, you may be eligible for for use of the drug if you have a serious disease for which there is no good alternative. If you believe that is the case then you use the contact information number on the clinical trials page .

I am wondering if Taape might find some assistance with this approach either with the forteo or denosumab. Taape , let us know how this goes if you decide to pursue this.